Bioactive Materials (Mar 2023)

An esterase-responsive ibuprofen nano-micelle pre-modified embryo derived nucleus pulposus progenitor cells promote the regeneration of intervertebral disc degeneration

  • Kai-shun Xia,
  • Dong-dong Li,
  • Cheng-gui Wang,
  • Li-wei Ying,
  • Jing-kai Wang,
  • Biao Yang,
  • Jia-wei Shu,
  • Xian-peng Huang,
  • Yu-ang Zhang,
  • Chao Yu,
  • Xiao-peng Zhou,
  • Fang-cai Li,
  • Nigel K.H. Slater,
  • Jian-bin Tang,
  • Qi-xin Chen,
  • Cheng-zhen Liang

Journal volume & issue
Vol. 21
pp. 69 – 85

Abstract

Read online

Stem cell-based transplantation is a promising therapeutic approach for intervertebral disc degeneration (IDD). Current limitations of stem cells include with their insufficient cell source, poor proliferation capacity, low nucleus pulposus (NP)-specific differentiation potential, and inability to avoid pyroptosis caused by the acidic IDD microenvironment after transplantation. To address these challenges, embryo-derived long-term expandable nucleus pulposus progenitor cells (NPPCs) and esterase-responsive ibuprofen nano-micelles (PEG-PIB) were prepared for synergistic transplantation. In this study, we propose a biomaterial pre-modification cell strategy; the PEG-PIB were endocytosed to pre-modify the NPPCs with adaptability in harsh IDD microenvironment through inhibiting pyroptosis. The results indicated that the PEG-PIB pre-modified NPPCs exhibited inhibition of pyroptosis in vitro; their further synergistic transplantation yielded effective functional recovery, histological regeneration, and inhibition of pyroptosis during IDD regeneration. Herein, we offer a novel biomaterial pre-modification cell strategy for synergistic transplantation with promising therapeutic effects in IDD regeneration.

Keywords